Filing Details
- Accession Number:
- 0001415889-24-022245
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-26 18:07:20
- Reporting Period:
- 2024-08-22
- Accepted Time:
- 2024-08-26 18:07:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1392380 | Gevo Inc. | GEVO | Industrial Organic Chemicals (2860) | 870747704 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1512143 | Michael Christopher Ryan | C/O Gevo, Inc. 345 Inverness Drive South Building C, Suite 310 Englewood CO 80112 | President & Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-08-22 | 84,014 | $0.76 | 1,573,934 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 26,921 | Indirect | By 401(k) Plan |
Footnotes
- Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 25, 2024.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.71 to $0.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.